BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 4148915)

  • 1. Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6-hydroxydopamine.
    Breese GR; Traylor TD
    Br J Pharmacol; 1972 Feb; 44(2):210-22. PubMed ID: 4148915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intraventricular injections of 6-hydroxydopamine in neonatal rats on the catecholamine levels and tyrosine hydroxylase activity in brain regions at maturity.
    Peters DA; Pappas BA; Taub H; Saari M
    Biochem Pharmacol; 1977 Dec; 26(23):2211-5. PubMed ID: 22332
    [No Abstract]   [Full Text] [Related]  

  • 3. Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine.
    Breese GR; Traylor TD
    Br J Pharmacol; 1971 May; 42(1):88-99. PubMed ID: 5580702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth and behavioral changes in developing rats treated intracisternally with 6-hydroxydopamine: evidence for involvement of brain dopamine.
    Smith RD; Cooper BR; Breese GR
    J Pharmacol Exp Ther; 1973 Jun; 185(3):609-19. PubMed ID: 4145870
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of various 6-hydroxydopamine treatments during development on growth and ingestive behavior.
    Breese GR; Smith RD; Cooper BR
    Pharmacol Biochem Behav; 1975; 3(6):1097-106. PubMed ID: 4816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional changes in [3H]-noradrenaline uptake, catecholamines and catecholamine synthetic and catabolic enzymes in rat brain following neonatal 6-hydroxydopamine treatment.
    Jonsson G; Sachs C
    Med Biol; 1976 Aug; 54(4):286-97. PubMed ID: 8670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain.
    Rastogi RB; Singhal RL
    J Pharmacol Exp Ther; 1976 Sep; 198(3):609-18. PubMed ID: 978462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of postnatal 6-hydroxydopamine treatment on tissue catecholamine levels.
    Lytle LD; Shoemaker WJ; Cottman K; Wurtman RJ
    J Pharmacol Exp Ther; 1972 Oct; 183(1):56-64. PubMed ID: 5080034
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of selective depletion of brain regional noradrenaline by systemic 6-hydroxydopamine in newborn rats.
    Liew MC; Laverty R
    Eur J Pharmacol; 1975 Aug; 33(1):165-72. PubMed ID: 1175683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Hydroxydopamine induced degeneration of noradrenaline neurons in the scorbutic guinea-pig.
    Jonsson G; Lohmander S; Sachs C
    Biochem Pharmacol; 1974 Sep; 23(18):2585-93. PubMed ID: 4153539
    [No Abstract]   [Full Text] [Related]  

  • 11. Tyrosine hydroxylase activity in brain regions after intraventricular 6-hydroxydopamine in the neonatal rat.
    Peters DA; Pappas BA; Taub H; Saari M
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):161-4. PubMed ID: 28554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Learning impairment in rats after 6-hydroxydopamine-induced depletion of brain catecholamines.
    Mason ST; Iverson SD
    Nature; 1974 Apr; 248(5450):697-8. PubMed ID: 4151498
    [No Abstract]   [Full Text] [Related]  

  • 13. Neonatal 6-hydroxydopamine treatment: noradrenaline levels and in vitro 3H-catecholamine synthesis in discrete brain regions of adult rats.
    Versteeg DH; van Ree JM; Provoost AP; de Jong W
    Life Sci; 1974 Dec; 15(12):2127-34. PubMed ID: 4621009
    [No Abstract]   [Full Text] [Related]  

  • 14. Modification and characterization of the permanent sympathectomy produced by the administration of guanethidine to newborn rats.
    Johnson EM; O'Brien F; Werbitt R
    Eur J Pharmacol; 1976 May; 37(1):45-54. PubMed ID: 6291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction.
    Pappas BA; Gallivan JV; Dugas T; Saari M; Ings R
    Psychopharmacology (Berl); 1980; 70(1):41-6. PubMed ID: 6775333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous tyrosine hydroxylase activity in the developing chick heart: a possible source of extraneuronal catecholamines.
    Stewart DE; Kirby ML
    J Mol Cell Cardiol; 1985 Apr; 17(4):389-98. PubMed ID: 2862286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of central early postnatal 6-hydroxydopamine administration on brain catecholamines and pituitary-adrenal function in adulthood.
    Kaplanski J; Nyakas C; van Delft AM; Smelik PG
    Neuroendocrinology; 1973-1974; 13(1):123-7. PubMed ID: 4779045
    [No Abstract]   [Full Text] [Related]  

  • 18. The Role of the Brain in the Regulation of Peripheral Organs-Noradrenaline Sources in Neonatal Rats: Noradrenaline Synthesis Enzyme Activity.
    Murtazina AR; Nikishina YO; Ugrumov MV
    Dokl Biochem Biophys; 2020 Jul; 493(1):201-204. PubMed ID: 32894465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and functional evaluation of the sympathectomy produced by the administration of guanethidine to newborn rats.
    Johnson EM; Cantor E; Douglas JR
    J Pharmacol Exp Ther; 1975 May; 193(2):503-12. PubMed ID: 238023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compensatory increase in tyrosine hydroxylase activity in rat brain after intraventricular injections of 6-hydroxydopamine.
    Acheson AL; Zigmond MJ; Stricker EM
    Science; 1980 Feb; 207(4430):537-40. PubMed ID: 6101509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.